Cognitive Decline Risk Factors Symptoms Biomarkers Cognitive Function Research Studies Clinical Trials Diagnosis Research Genetic Risk Factors Dementia Parkinson's Disease Treatment Options Cognitive Resilience Treatment Cognitive Impairment Pathology Genetic Factors Memory Processing Tau Tangles Cytokines Neurodegenerative Disorders Risk Reduction Down Syndrome Protein Markers Memory Impairments BACE1 Protein Causes Early-Onset Alzheimer's Brain Morphology Disease Modeling Genetic Predisposition Research Advances Gender Differences Brain Aging Agitation Environmental Factors Prevention Vascular Health Treatment Approaches Drug Trials Clinical Research Sex Differences Beta-Amyloids Drug Repurposing Cerebrospinal Fluid Glymphatic System Occupational Health Amyloid Plaques Cytomegalovirus Drug Treatments Herpesviruses Cognitive Disorders Posterior Cortical Atrophy Complications Early Detection Treatment Approval Amyloid Plaque Genetic Causes Research on Alzheimer's
Axsome’s submission is backed by four Phase 3 studies alongside long-term safety data.
